Toulouse, France

Yves Trehin

This inventor holds 4 USPTO granted patents and 3 published patent applications. Top assignees: Antialis, Other. Active years: 2006-2012.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Yves Trehin. Retrieved from https://idiyas.com/inventor/yves-trehin

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

Calculating rank
USPTO Granted Patents = 4 

Average Co-Inventor Count = 3.4

ph-index = 3

Forward Citations = 30(Granted Patents)


Location History:

  • Toulouse, FR (2006 - 2012)
  • Blesle, FR (2012)

Company Filing History:


Years Active: 2006-2012

Loading Chart...
4 patents (USPTO):Explore Patents

Title: Yves Trehin: Innovator in Medical Treatments from Toulouse, France

Introduction

Yves Trehin, an accomplished inventor based in Toulouse, France, has made significant contributions to the field of medical treatment through his innovative patent work. With a total of four patents to his name, Trehin's research focuses primarily on the role of histamine in various diseases, showcasing his commitment to advancing healthcare solutions.

Latest Patents

Among his latest patents, one notable invention revolves around the treatment of diseases modulated by a H4 receptor agonist. This invention encompasses a method for treating conditions related to the H4 receptor by administering an effective amount of a H4R agonist. Furthermore, it includes a comprehensive approach to treating Chronic Obstructive Pulmonary Disease (COPD) by combining a H4R agonist, a H1R antagonist, and an anticholinergic drug. Additionally, his research provides a pharmaceutical formulation that combines a H4R agonist with another active agent, along with a pharmaceutically acceptable carrier. His other significant patent addresses the treatment of COPD, gastro-esophageal reflux disease (GERD), food allergies, and other gastrointestinal disorders through proper histamine management using a combination of histidine decarboxylase inhibitors and various histamine receptor drugs.

Career Highlights

Yves Trehin has enjoyed a productive career, marked by his innovative thinking and dedication to developing effective treatments. His background includes working with various companies that furthered his exposure to the pharmaceutical industry. Notably, he was associated with Antialis, where his skills and knowledge contributed to ongoing projects and advancements in medical treatments.

Collaborations

Throughout his career, Trehin has collaborated with notable individuals in the field, including Emile Loria and Gaetan Terrasse. These professional relationships have enabled the exchange of ideas and have fostered an environment conducive to innovation and creativity in their respective projects.

Conclusion

Yves Trehin stands out as a forward-thinking inventor whose work addresses critical healthcare challenges through innovative methods and formulations. His contributions to the treatment of diseases linked to histamine modulation are paving the way for enhanced therapeutic options. With continued collaboration and exploration, Trehin's impact on medicine is poised to grow even further in the years to come.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…